Clinical Trial Update: Non-myeloablative Allogeneic Transplantation for the Treatment of Multiple Myeloma [Phase 2]

View source ↗

Summary

Phase 2 trial update on non-myeloablative allogeneic transplantation for multiple myeloma; study completed with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Snippet

Sponsor: Wen-Kai Weng | Conditions: Blood Cancer, Multiple Myeloma | Phase 2 | Status: COMPLETED | Results posted: 2018-01-18